Indicators

Markets:

News

Latest News about AMRX

Recent news which mentions AMRX

< Previous 1 2 3 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session

August 31, 2022

Stocks That Hit 52-Week Lows On Thursday

August 11, 2022

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases

August 05, 2022

Amneal Pharma Posts Mixed Q2 Earnings, Cuts Profit Outlook For 2022

August 05, 2022

Recap: Amneal Pharmaceuticals Q2 Earnings

August 05, 2022

Earnings Scheduled For August 5, 2022

August 05, 2022

Amneal Pharmaceuticals's Earnings: A Preview

August 04, 2022

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

May 04, 2022

Recap: Amneal Pharmaceuticals Q1 Earnings

May 04, 2022

Amneal Pharmaceuticals's Earnings Outlook

May 03, 2022

21 Stocks Moving in Monday's Pre-Market Session

April 18, 2022

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More

April 14, 2022

Amneal Scores Second US Biosimilars Approval With Alymsys In Oncology

April 14, 2022

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight

April 03, 2022

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

April 01, 2022

The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill

March 18, 2022

Amneal Pharmaceuticals's Return On Capital Employed Insights

March 08, 2022

Amneal Pharma's Q4 Earnings Fall Short Of Expectations, Sees FY22 Sales Growth Of 7%

March 02, 2022

The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi

March 02, 2022

Recap: Amneal Pharmaceuticals Q4 Earnings

March 02, 2022

Earnings Scheduled For March 2, 2022

March 02, 2022

Amneal Pharmaceuticals's Earnings: A Preview

March 01, 2022

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight

February 27, 2022

The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets

January 05, 2022

Amneal's $83M Saol Acquisition Deal Expands Its Neurology Presence Into Spasticity

January 05, 2022

12 Health Care Stocks Moving In Friday's After-Market Session

December 17, 2021

TherapeuticsMD, Amneal Settle US Patent Litigation For Bijuva

December 08, 2021

The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom

December 08, 2021

Amneal Pharmaceuticals, inc (AMRX) Q3 2021 Earnings Call Transcript

November 03, 2021

Amneal Posts Mixed Bag Q3 Earnings; Acquires Puniska To Bolster Injectable Business

November 03, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.